What happened inside Khazanah's RM2 billion biotech fund

Xeraya Capital once managed around US$500 million in assets.

Now Khazanah has ordered a forensic investigation into historical transactions after irregularities were found in documentation.

So far, there’s no public finding of stolen money, no charges, and we still don’t know which deals are involved.

The big question now: what exactly did they find?